Kintara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

TuHURA Biosciences

29/09/2021 15:48

* Kintara Therapeutics Inc  KTRA.OQ  reported a quarterly
adjusted loss of 13 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 16 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Kintara Therapeutics Inc's reported EPS for the quarter was a
loss of 13 cents​.
* The mean earnings estimate of analysts had risen by about 1.5%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Kintara Therapeutics Inc shares had fallen by 61.8% this
quarter and lost 32.3% so far this year.
* The company reported a quarterly loss of $6.74 million.
* Wall Street's median 12-month price target for Kintara
Therapeutics Inc is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated September 29 at 02:48 p.m.
 ​All figures in US dollars unless otherwise stated